Seongju Jeong

7PUBLICATIONS
18CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityInfectious agentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2025
Author Correction: A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity.

Joon Seok, Sung-Dong Cho, Jeongsoo Lee

|Jun 26, 2023
A virtual memory CD8+ T cell-originated subset causes alopecia areata through innate-like cytotoxicity.

Joon Seok, Sung-Dong Cho, Jeongsoo Lee

|Mar 29, 2022
IFITM3 Is Upregulated Characteristically in IL-15-Mediated Bystander-Activated CD8+ T Cells during Influenza Infection.

Seongju Jeong, Minwoo Jeon, Hoyoung Lee

|Aug 06, 2021
Significance of bystander T cell activation in microbial infection.

Hoyoung Lee, Seongju Jeong, Eui-Cheol Shin

|Jul 07, 2021
Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade.

Seongju Jeong, Eunyoung Park, Hyung-Don Kim

|Mar 12, 2020
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy.

Seongju Jeong, Su-Hyung Park

Pageof 2

Frequent Collaborators

4 joint publications

Su-Hyung Park

4 joint publications

Eui-Cheol Shin

2 joint publications

Sang-Jun Ha

2 joint publications

Jong Hoon Kim